about
New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricleAdvanced techniques for chronic lead extraction: heading from the laser towards the evolution system.Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study.Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification.Substrate mapping strategies for successful ablation of ventricular tachycardia: a review.Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group.Ventricular Tachycardia Ablation in Severe Heart Failure: An International Ventricular Tachycardia Ablation Center Collaboration Analysis.Electroanatomical voltage and morphology characteristics in postinfarction patients undergoing ventricular tachycardia ablation: pragmatic approach favoring late potentials abolition.Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation.Predictors of advanced lead extraction based on a systematic stepwise approach: results from a high volume center.Electrophysiological evaluation of asymptomatic ventricular pre-excitation in children and adolescents.Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival.Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation.Extracorporeal Membrane Oxygenation for Hemodynamic Support of Ventricular Tachycardia Ablation.Ventricular Tachycardia Ablation in the Elderly: An International Ventricular Tachycardia Center Collaborative Group Analysis.New diagnostic criteria for identifying left-sided ventricular ectopy using non-contact mapping and virtual unipolar electrogram analysis.Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia.Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.Late potentials abolition reduces ventricular tachycardia recurrence after ablation especially in higher-risk patients with a chronic total occlusion in an infarct-related artery.Familial recurrence of anomalous origin of right pulmonary artery from the aortaGenetic heterogeneity and phenotypic anomalies in children with atrioventricular canal defect and tetralogy of Fallot[Current integrated approaches for the treatment of focal atrial tachycardia]Thoracoscopic appendage exclusion with an atriclip device as a solo treatment for focal atrial tachycardiaLate potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablationChanges in the propagation pattern within the conduction channel during sinus rhythm and ventricular tachycardia demonstrated by non-contact mapping: role of late potential activityElectrical storm induced by cardiac resynchronization therapy is determined by pacing on epicardial scar and can be successfully managed by catheter ablationContact force monitoring for cardiac mapping in patients with ventricular tachycardiaApplication of ripple mapping to visualize slow conduction channels within the infarct-related left ventricular scarImpact of a chronic total occlusion in an infarct-related artery on the long-term outcome of ventricular tachycardia ablationReply: Elimination of All Inducible Ventricular Tachycardias as the Endpoint for AblationImaging and epicardial substrate ablation of ventricular tachycardia in patients late after myocarditisManagement of atrial fibrillation
P50
Q24298150-9A5DA883-1FA6-45A2-A013-8C4B815BAE06Q34706521-2DF17061-2B32-4C5A-BD1C-0E03CE2F403FQ35995550-70D5FB17-780C-40CB-913C-7CB2BE07118EQ37102131-CE34B63D-C19B-498A-AAD3-A0A52953CDE0Q38106520-F5EAD866-043D-4792-9A8C-7FF7EA085365Q38785002-EF26B5EF-EAE9-4C4C-80B2-73EC98FD844DQ40382898-D9776D78-30FC-46AE-BE8C-7E1F753F176CQ40892257-13329F2B-B85C-499C-A3CF-CA68459FB98DQ44654348-9ED7567B-C573-47E2-A315-B0E731EF0198Q44763903-66209092-8A90-48E9-93D1-196566E92494Q45248132-86C1C92F-444B-4C34-B66E-D5BE69DB56D5Q46720759-ED57394E-B75E-4D76-9A8C-4A1A15344140Q47276899-3E243E93-0A05-4CE2-B565-DF994519D436Q47355726-4E6E3B90-CD24-406D-9F46-36CB635311DEQ48533547-E40E3A0A-28EE-471F-93C4-2A80D46AC274Q51073919-F211C3E4-531A-488E-90D4-487465FF1C9AQ51141058-8ABE4CC9-E9D7-406B-94F1-D01BB9C66777Q51734894-DBCCBF04-DCA6-4296-9B91-930443118DC1Q51738573-69E7CBC4-A2E9-4579-B5F6-D380A4F6555AQ51739843-B02F83CD-445D-4F77-80D5-7ADC607235C8Q82759280-B4ACBFF8-B6BE-4A29-A7C3-19165F115235Q82797624-BB09A027-B52F-4215-83A7-F28F71F70DCEQ83696728-E5C1F3EC-F334-4C1A-ADBC-9AD63724D1E8Q83831049-041155EF-5A98-4751-ABEA-4C403143B9DBQ83838921-12AC5630-C6CC-4B6F-9B90-86431DFF0367Q84622888-DC01496D-A541-45C1-B36C-53EE8747E831Q85310278-CC65D7B9-4EE0-4AF5-B32E-FB3E74A26C7CQ86039419-08C8C6D8-C6A3-40CE-9285-8EB80B83149BQ86360827-9F64A27C-2BFF-4F5E-AB3F-184A4781CA8AQ86552502-FB6256D1-24CE-4593-ADA1-3914BBB06DFFQ86883819-4BB31CF2-7FBB-4CA9-8D9E-93DD2AEC7E9DQ87337095-57F74F81-7098-4BC3-BFF4-C300F9E136F2Q87752222-DBE3F638-D22B-4871-9493-F54983EFFC81
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7751-6871
@en
name
Pasquale Vergara
@ast
Pasquale Vergara
@en
Pasquale Vergara
@es
Pasquale Vergara
@nl
type
label
Pasquale Vergara
@ast
Pasquale Vergara
@en
Pasquale Vergara
@es
Pasquale Vergara
@nl
prefLabel
Pasquale Vergara
@ast
Pasquale Vergara
@en
Pasquale Vergara
@es
Pasquale Vergara
@nl
P106
P1153
7006757888
P21
P31
P496
0000-0001-7751-6871